Cellectis S.A. ( CLLS) - Key Metrics
CLLS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.10 | -$0.26 | -$0.11 | -$0.11 |
| 2025Q3 | $0.35 | $0.01 | -$0.02 | -$0.03 |
| 2025Q2 | $0.17 | -$0.24 | -$0.10 | -$0.11 |
| 2025Q1 | $0.11 | -$0.18 | -$0.17 | -$0.18 |
CLLS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.66 |
| 2025Q3 | ? | 117.92 |
| 2025Q2 | ? | -1.59 |
| 2025Q1 | ? | -1.79 |
CLLS
Price: $3.09
52 week price:
Earnings Per Share: -0.67 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 1.9 million
Ebitda: -29.3 millionMarket Capitalization: 307.3 million